The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.本發明係關於抗病毒劑的化合物。明確而言本發明化合物可抑制HCV的複製而因此可有效用於治療C型肝炎的感染。本發明亦係關於含有這些化合物的醫藥組成物以及其製造方法。
